Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Benhamou

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Radiation Research|March 1, 1993
Long-term effects on the thyroid of irradiation for skin angiomas in childhoodF de Vathaire, P Fragu, P François, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2009
Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumorsC Bouchardy, E Rapiti, M Usel, et al.
Cancer|December 1, 1995
Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). IGR Breast Cancer GroupJ A Dewar, R Arriagada, S Benhamou, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoinG C Ibeanu, J Blaisdell, R J Ferguson, et al.
Pharmacogenetics|February 18, 1999
An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in CaucasiansG C Ibeanu, J Blaisdell, B I Ghanayem, et al.
International Journal of Cancer|October 16, 1999
Exposure to environmental tobacco smoke and risk of adenocarcinoma of the lungP Boffetta, W Ahrens, F Nyberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patientsR Arriagada, T Le Chevalier, A Rivière, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2001
Re: Spitz, M. R., Duphorne, C. M., Detry, M. A., Pillow, P. C., Amos, C. I., Lei, L., de Andrade, M., Gu, X., Hong, W. K., and Wu, X. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol. Biomark. Prev., 9: 1017-1020, 2000S Lewis, P Brennan, F Nyberg, et al.
IARC Scientific Publications|December 18, 2002
Cruciferous vegetable intake, GSTM1 genotype and lung cancer risk in a non-smoking populationS Lewis, P Brennan, F Nyberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2005
Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokersT Dutu, S Michiels, P Fouret, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Radiation Research|March 1, 1993
Long-term effects on the thyroid of irradiation for skin angiomas in childhoodF de Vathaire, P Fragu, P François, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2009
Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumorsC Bouchardy, E Rapiti, M Usel, et al.
Cancer|December 1, 1995
Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). IGR Breast Cancer GroupJ A Dewar, R Arriagada, S Benhamou, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoinG C Ibeanu, J Blaisdell, R J Ferguson, et al.
Pharmacogenetics|February 18, 1999
An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in CaucasiansG C Ibeanu, J Blaisdell, B I Ghanayem, et al.
International Journal of Cancer|October 16, 1999
Exposure to environmental tobacco smoke and risk of adenocarcinoma of the lungP Boffetta, W Ahrens, F Nyberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patientsR Arriagada, T Le Chevalier, A Rivière, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2001
Re: Spitz, M. R., Duphorne, C. M., Detry, M. A., Pillow, P. C., Amos, C. I., Lei, L., de Andrade, M., Gu, X., Hong, W. K., and Wu, X. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol. Biomark. Prev., 9: 1017-1020, 2000S Lewis, P Brennan, F Nyberg, et al.
IARC Scientific Publications|December 18, 2002
Cruciferous vegetable intake, GSTM1 genotype and lung cancer risk in a non-smoking populationS Lewis, P Brennan, F Nyberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2005
Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokersT Dutu, S Michiels, P Fouret, et al.
Pageof 11